We are investigating ways to detect cancer signals sooner, such as using measurements of circulating tumour DNA to identify patients who are most at risk of their cancer returning – to inform a personalised treatment strategy.
However, it is an unfortunate reality that many cancers are identified and diagnosed in the metastatic setting; we need to identify and treat disease earlier for optimal outcomes. We are investigating ways to detect cancer signals sooner, such as using measurements of circulating tumour DNA to identify patients who are most at risk of their cancer returning – to inform a personalised treatment strategy.